| Product Code: ETC8596571 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Niger`s import shipments of amlodipine besylate in 2024 saw a notable shift in concentration, moving from low to moderate concentration levels. Top exporting countries such as India, France, and Egypt continued to lead the market, with China and Denmark also making significant contributions. Despite a negative compound annual growth rate (CAGR) from 2020 to 2024, the sector experienced a strong growth spurt from 2023 to 2024, indicating a potential resurgence in demand for amlodipine besylate in Niger. This trend suggests opportunities for stakeholders to capitalize on the increasing market demand for this pharmaceutical product.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Niger Amlodipine Besylate Market Overview |
3.1 Niger Country Macro Economic Indicators |
3.2 Niger Amlodipine Besylate Market Revenues & Volume, 2021 & 2031F |
3.3 Niger Amlodipine Besylate Market - Industry Life Cycle |
3.4 Niger Amlodipine Besylate Market - Porter's Five Forces |
3.5 Niger Amlodipine Besylate Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Niger Amlodipine Besylate Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Niger Amlodipine Besylate Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of hypertension and cardiovascular diseases in Niger |
4.2.2 Growing awareness about the importance of managing hypertension |
4.2.3 Rising disposable income leading to increased affordability of amlodipine besylate |
4.3 Market Restraints |
4.3.1 Lack of healthcare infrastructure in certain regions of Niger |
4.3.2 Limited access to healthcare services in rural areas |
4.3.3 Presence of alternative treatment options for hypertension |
5 Niger Amlodipine Besylate Market Trends |
6 Niger Amlodipine Besylate Market, By Types |
6.1 Niger Amlodipine Besylate Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Niger Amlodipine Besylate Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Niger Amlodipine Besylate Market Revenues & Volume, By 2.5mg Tablets, 2021- 2031F |
6.1.4 Niger Amlodipine Besylate Market Revenues & Volume, By 5mg Tablets, 2021- 2031F |
6.1.5 Niger Amlodipine Besylate Market Revenues & Volume, By 10mg Tablets., 2021- 2031F |
6.2 Niger Amlodipine Besylate Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Niger Amlodipine Besylate Market Revenues & Volume, By High Blood Pressure, 2021- 2031F |
6.2.3 Niger Amlodipine Besylate Market Revenues & Volume, By Heart Diseases, 2021- 2031F |
7 Niger Amlodipine Besylate Market Import-Export Trade Statistics |
7.1 Niger Amlodipine Besylate Market Export to Major Countries |
7.2 Niger Amlodipine Besylate Market Imports from Major Countries |
8 Niger Amlodipine Besylate Market Key Performance Indicators |
8.1 Number of prescriptions of amlodipine besylate by healthcare providers |
8.2 Patient adherence rates to amlodipine besylate treatment regimen |
8.3 Number of healthcare facilities offering amlodipine besylate treatment |
8.4 Rate of hypertension control among patients using amlodipine besylate |
9 Niger Amlodipine Besylate Market - Opportunity Assessment |
9.1 Niger Amlodipine Besylate Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Niger Amlodipine Besylate Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Niger Amlodipine Besylate Market - Competitive Landscape |
10.1 Niger Amlodipine Besylate Market Revenue Share, By Companies, 2024 |
10.2 Niger Amlodipine Besylate Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |